Thermo Fisher Scientific Acquires Finnzymes

Thermo Fisher Scientific Acquires Affymetrix

March 31, 2016

Biotechnology

Thermo Fisher Scientific has completed its acquisition of Affymetrix for $14.00 per share in cash, representing an approximate total purchase price of $1.3 billion, following approval by Affymetrix stockholders. The deal brings Affymetrix's genetic analysis products and expanded antibody portfolio into Thermo Fisher's life sciences offerings to strengthen its capabilities in biosciences and clinical/applied markets.

Thermo Fisher Scientific Acquires Brammer Bio for $1.7 Billion

March 25, 2019

Biotechnology

Thermo Fisher Scientific agreed to acquire Brammer Bio, a viral vector CDMO focused on gene and cell therapies, for approximately $1.7 billion in cash. The deal expands Thermo Fisher’s pharma services and viral vector manufacturing capabilities to support high-growth gene and cell therapy markets and brings a team of nearly 600 employees into its pharma services business.

Thermo Fisher Scientific Acquires Olink Holding AB

July 10, 2024

Biotechnology

Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.

Thermo Fisher Scientific Acquires Core Informatics

March 6, 2017

Cloud & SaaS

Thermo Fisher Scientific has acquired Core Informatics, a Branford, Connecticut–based provider of cloud-based laboratory informatics platforms including LIMS, ELN and SDMS. The acquisition expands Thermo Fisher’s cloud and digital-lab capabilities by integrating Core’s Platform for Science into Thermo Fisher’s informatics and instrument ecosystem to better serve biopharma, genomics and industrial scientific customers.

Thermo Fisher Scientific Acquires Solventum's Purification & Filtration Business

September 2, 2025

Manufacturing

Thermo Fisher Scientific completed the acquisition of Solventum's Purification & Filtration business for approximately $4.0 billion in cash. The divested business—now Thermo Fisher's Filtration and Separation business—adds bioprocessing filtration, industrial filtration and membrane technologies to Thermo Fisher's Life Sciences Solutions portfolio and is expected to generate about $750 million in revenue in 2025.

Thermo Fisher Scientific Acquires PPD, Inc.

December 8, 2021

Healthcare Services

Thermo Fisher Scientific completed the acquisition of PPD, Inc. for $17.4 billion in cash, plus the assumption of approximately $3.0–$3.5 billion of net debt. The deal brings PPD's global clinical research and laboratory services into Thermo Fisher's Laboratory Products and Services segment, expanding Thermo Fisher's capabilities in clinical development and expected to generate approximately $125 million of synergies by year three.